Response Biomedical Gets FDA OK for H1N1 Reactivity Info in Assay Package Insert

The FDA cleared analytical reactivity information to be added to a package insert for the firm's RAMP Influenza A/B Assay.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories